ASH

No analysis generated yet. Run the pipeline for this company.

AI-extracted key facts from press releases and SEC filings. Significance 1–10.

5

EarningsBearishSEC 8-KMar 27, 2026

United-Guardian FY25 net sales $10.5M, down 13%; EPS $0.46 vs $0.71 prior year

▸FY25 net sales $10.55M, down 13% YoY from $12.18M
▸FY25 net income $2.11M ($0.46/share) vs $3.25M ($0.71/share) in 2024
▸Cosmetic ingredient sales declined due to distributor inventory overstock and global competition
▸Pharmaceutical sales +15% and medical lubricant sales +4% YoY
▸Renacidin approved for inclusion on two major pharmacy benefit manager formularies

Ashland Global